RATIONALE: An acute-care visit for asthma often signals a management failure. Although a written action plan is effective when combined with self-management education and regular medical review, its independent value remains controversial. OBJECTIVES: We examined the efficacy of providing a written action plan coupled with a prescription (WAP-P) to improve adherence to medications and other recommendations in a busy emergency department. METHODS: We randomized 219 children aged 1-17 years to receive WAP-P (n = 109) or unformatted prescription (UP) (n = 110). All received fluticasone and albuterol inhalers, fitted with dose counters, to use at the discretion of the emergency physician. The main outcome was adherence to fluticasone (use/prescribed × 100%) over 28 days. Secondary outcomes included pharmacy dispensation of oral corticosteroids, β(2)-agonist use, medical follow-up, asthma education, acute-care visits, and control. MEASUREMENTS AND MAIN RESULTS: Although both groups showed a similar drop in adherence in the initial 14 days, adherence to fluticasone was significantly higher over Days 15-28 in children receiving WAP-P (mean group difference, 16.13% [2.09, 29.91]). More WAP-P than UP patients filled their oral corticosteroid prescription (relative risk, 1.31 [1.07, 1.60]) and were well-controlled at 28 days (1.39 [1.04, 1.86]). Compared with UP, use of WAP-P increased physicians' prescription of maintenance fluticasone (2.47 [1.53, 3.99]) and recommendation for medical follow-up (1.87 [1.48, 2.35]), without group differences in other outcomes. CONCLUSIONS: Provision of a written action plan significantly increased patient adherence to inhaled and oral corticosteroids and asthma control and physicians' recommendation for maintenance fluticasone and medical follow-up, supporting its independent value in the acute-care setting. Clinical trial registered with www.clinicaltrials.gov (NCT 00381355).
RCT Entities:
RATIONALE: An acute-care visit for asthma often signals a management failure. Although a written action plan is effective when combined with self-management education and regular medical review, its independent value remains controversial. OBJECTIVES: We examined the efficacy of providing a written action plan coupled with a prescription (WAP-P) to improve adherence to medications and other recommendations in a busy emergency department. METHODS: We randomized 219 children aged 1-17 years to receive WAP-P (n = 109) or unformatted prescription (UP) (n = 110). All received fluticasone and albuterol inhalers, fitted with dose counters, to use at the discretion of the emergency physician. The main outcome was adherence to fluticasone (use/prescribed × 100%) over 28 days. Secondary outcomes included pharmacy dispensation of oral corticosteroids, β(2)-agonist use, medical follow-up, asthma education, acute-care visits, and control. MEASUREMENTS AND MAIN RESULTS: Although both groups showed a similar drop in adherence in the initial 14 days, adherence to fluticasone was significantly higher over Days 15-28 in children receiving WAP-P (mean group difference, 16.13% [2.09, 29.91]). More WAP-P than UP patients filled their oral corticosteroid prescription (relative risk, 1.31 [1.07, 1.60]) and were well-controlled at 28 days (1.39 [1.04, 1.86]). Compared with UP, use of WAP-P increased physicians' prescription of maintenance fluticasone (2.47 [1.53, 3.99]) and recommendation for medical follow-up (1.87 [1.48, 2.35]), without group differences in other outcomes. CONCLUSIONS: Provision of a written action plan significantly increased patient adherence to inhaled and oral corticosteroids and asthma control and physicians' recommendation for maintenance fluticasone and medical follow-up, supporting its independent value in the acute-care setting. Clinical trial registered with www.clinicaltrials.gov (NCT 00381355).
Authors: Alexander F Glick; Jonathan S Farkas; Joseph Nicholson; Benard P Dreyer; Melissa Fears; Christopher Bandera; Tanya Stolper; Nicole Gerber; H Shonna Yin Journal: Pediatrics Date: 2017-08 Impact factor: 7.124
Authors: Molly A Martin; Valerie G Press; Kim Erwin; Helen Margellos-Anast; Stacy Ignoffo; Kate Sheridan McMahon; Giselle Mosnaim; Jessica Ramsay; S Margaret Paik Journal: J Asthma Date: 2017-07-18 Impact factor: 2.515
Authors: Jill M Plevinsky; Ana M Gutierrez-Colina; Julia K Carmody; Kevin A Hommel; Lori E Crosby; Meghan E McGrady; Ahna L H Pai; Rachelle R Ramsey; Avani C Modi Journal: J Pediatr Psychol Date: 2020-04-01
Authors: Jerry A Krishnan; Molly A Martin; Cortland Lohff; Giselle S Mosnaim; Helen Margellos-Anast; Julie A DeLisa; Kate McMahon; Kim Erwin; Leslie S Zun; Michael L Berbaum; Michael McDermott; Nina E Bracken; Rajesh Kumar; S Margaret Paik; Sharmilee M Nyenhuis; Stacy Ignoffo; Valerie G Press; Zachary E Pittsenbarger; Trevonne M Thompson Journal: Contemp Clin Trials Date: 2017-03-31 Impact factor: 2.226
Authors: Arlene M Butz; Jill S Halterman; Melissa Bellin; Joan Kub; Kevin D Frick; Cassia Lewis-Land; Jennifer Walker; Michele Donithan; Mona Tsoukleris; Mary Elizabeth Bollinger Journal: J Asthma Date: 2012-09-19 Impact factor: 2.515
Authors: Beverley J Sheares; Robert B Mellins; Emily Dimango; Denise Serebrisky; Yuan Zhang; Michael R Bye; Mark E Dovey; Sami Nachman; Vincent Hutchinson; David Evans Journal: Am J Respir Crit Care Med Date: 2015-06-15 Impact factor: 21.405